Host responses to herpes simplex virus and herpes simplex virus vectors

被引：6

作者：

Hukkanen, Veijo ^{[1
]}

Paavilainen, Henrik

Mattila, Riikka K. ^{[2
]}

机构：

[1] Univ Turku, Dept Virol, FIN-20520 Turku, Finland

[2] Univ Oulu, Inst Diagnost, FIN-90014 Oulu, Finland

来源：

FUTURE VIROLOGY | 2010年 / 5卷 / 04期

基金：

芬兰科学院;

关键词：

apoptosis; autophagy; cytokine; gene therapy; herpes simplex virus; herpes simplex virus vector; human herpesvirus 1; innate immunity; interferon; Toll-like receptor; LATENCY-ASSOCIATED TRANSCRIPT; DOUBLE-STRANDED-RNA; CD8(+) T-CELLS; REGULATORY PROTEIN ICP27; NATURAL-KILLER-CELLS; TOLL-LIKE RECEPTORS; GENOME COPY NUMBER; NF-KAPPA-B; GAMMA-INTERFERON; IMMUNE-RESPONSES;

D O I：

10.2217/FVL.10.35

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Herpes simplex virus (HSV) is a well-known, ubiquitous pathogen of humans. Engineered mutants of HSV can also be exploited as vectors in gene therapy or for virotherapy of tumors. HSV has multiple abilities to evade and modulate the innate and adaptive responses of the host. The increasing knowledge on the mutual interactions of the invading HSV with the host defenses will contribute to our deeper understanding of the relationship between HSV and the host, and thereby lead to future development of more effective and specific HSV vectors for treatment of human diseases. The future advances of HSV vaccines and vaccine vectors are based on the knowlegde of the complex interplay between HSV and the host defenses.

引用

收藏

页码：493 / 512

页数：20

相关论文

共 237 条

[1] In the absence of T cells, natural killer cells protect from mortality due to HSV-1 encephalitis [J].

Adler, H ;

Beland, JL ;

Del-Pan, NC ;

Kobzik, L ;

Sobel, RA ;

Rimm, IJ .

JOURNAL OF NEUROIMMUNOLOGY, 1999, 93 (1-2) :208-213

[2] Herpes simplex virus 1 activates cdc2 to recruit topoisomerase IIα for post-DNA synthesis expression of late genes [J].

Advani, SJ ;

Weichselbaum, RR ;

Roizman, B .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (08) :4825-4830

[3] Lactoferrin and lactoferricin inhibit Herpes simplex 1 and 2 infection and exhibit synergy when combined with acyclovir [J].

Andersen, JH ;

Jenssen, H ;

Gutteberg, TJ .

ANTIVIRAL RESEARCH, 2003, 58 (03) :209-215

[4] Pseudotyping of glycoprotein D-deficient herpes simplex virus type 1 with vesicular stomatitis virus glycoprotein G enables mutant virus attachment and entry [J].

Anderson, DB ;

Laquerre, S ;

Goins, WF ;

Cohen, JB ;

Glorioso, JC .

JOURNAL OF VIROLOGY, 2000, 74 (05) :2481-2487

[5] Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukins [J].

Andreansky, S ;

He, B ;

van Cott, J ;

McGhee, J ;

Markert, JM ;

Gillespie, GY ;

Roizman, B ;

Whitley, RJ .

GENE THERAPY, 1998, 5 (01) :121-130

[6] Herpes Simplex Virus Type I infection: overview on relevant clinico-pathological features [J].

Arduino, Paolo G. ;

Porter, Stephen R. .

JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2008, 37 (02) :107-121

[7] Bimolecular Complementation Defines Functional Regions of Herpes Simplex Virus gB That Are Involved with gH/gL as a Necessary Step Leading to Cell Fusion [J].

Atanasiu, Doina ;

Whitbeck, J. Charles ;

de Leon, Manuel Ponce ;

Lou, Huan ;

Hannah, Brian P. ;

Cohen, Gary H. ;

Eisenberg, Roselyn J. .

JOURNAL OF VIROLOGY, 2010, 84 (08) :3825-3834

[8] The herpes simplex virus type 1 regulatory protein ICP27 is required for the prevention of apoptosis in infected human cells [J].

Aubert, M ;

Blaho, JA .

JOURNAL OF VIROLOGY, 1999, 73 (04) :2803-2813

[9] Modulation of apoptosis during herpes simplex virus infection in human cells [J].

Aubert, M ;

Blaho, JA .

MICROBES AND INFECTION, 2001, 3 (10) :859-866

[10] The Virological Synapse Facilitates Herpes Simplex Virus Entry into T Cells [J].

Aubert, Martine ;

Yoon, Miri ;

Sloan, Derek D. ;

Spear, Patricia G. ;

Jerome, Keith R. .

JOURNAL OF VIROLOGY, 2009, 83 (12) :6171-6183

← 1 2 3 4 5 6 7 8 9 10 →